Literature DB >> 21958592

Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample.

Jerod M Rasmussen1, Anita Lakatos, Theo G M van Erp, Frithjof Kruggel, David B Keator, James T Fallon, Fabio Macciardi, Steven G Potkin.   

Abstract

Careful selection of the reference region for non-quantitative positron emission tomography (PET) analyses is critically important for Region of Interest (ROI) data analyses. We introduce an empirical method of deriving the most suitable reference region for computing neurodegeneration sensitive (18)fluorodeoxyglucose (FDG) PET ratios based on the dataset collected by the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. Candidate reference regions are selected based on a heat map of the difference in coefficients of variation (COVs) of FDG ratios over time for each of the Automatic Anatomical Labeling (AAL) atlas regions normalized by all other AAL regions. Visual inspection of the heat map suggests that the portion of the cerebellum and vermis superior to the horizontal fissure is the most sensitive reference region. Analyses of FDG ratio data show increases in significance on the order of ten-fold when using the superior portion of the cerebellum as compared with the traditionally used full cerebellum. The approach to reference region selection in this paper can be generalized to other radiopharmaceuticals and radioligands as well as to other disorders where brain changes over time are hypothesized and longitudinal data is available. Based on the empirical evidence presented in this study, we demonstrate the usefulness of the COV heat map method and conclude that intensity normalization based on the superior portion of the cerebellum may be most sensitive to measuring change when performing longitudinal analyses of FDG-PET ratios as well as group comparisons in Alzheimer's disease. This article is part of a Special Issue entitled: Imaging Brain Aging and Neurodegenerative disease.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21958592      PMCID: PMC5849233          DOI: 10.1016/j.bbadis.2011.09.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

Review 1.  Alignment of magnetic-resonance brain datasets with the stereotactical coordinate system.

Authors:  F Kruggel; D Yves von Cramon
Journal:  Med Image Anal       Date:  1999-06       Impact factor: 8.545

2.  Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging.

Authors:  M Bentourkia; A Bol; A Ivanoiu; D Labar; M Sibomana; A Coppens; C Michel; G Cosnard; A G De Volder
Journal:  J Neurol Sci       Date:  2000-12-01       Impact factor: 3.181

3.  Effects of age on the glucose metabolic changes in mild cognitive impairment.

Authors:  Kejal Kantarci; M L Senjem; V J Lowe; H J Wiste; S D Weigand; B J Kemp; A R Frank; M M Shiung; B F Boeve; D S Knopman; R C Petersen; C R Jack
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

4.  Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization.

Authors:  Per Borghammer; Joel Aanerud; Albert Gjedde
Journal:  Neuroimage       Date:  2009-03-19       Impact factor: 6.556

5.  Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images.

Authors:  P T Fox; M A Mintun; E M Reiman; M E Raichle
Journal:  J Cereb Blood Flow Metab       Date:  1988-10       Impact factor: 6.200

6.  Clinical Dementia Rating (CDR).

Authors:  L Berg
Journal:  Psychopharmacol Bull       Date:  1988

7.  Multi-modal imaging predicts memory performance in normal aging and cognitive decline.

Authors:  K B Walhovd; A M Fjell; A M Dale; L K McEvoy; J Brewer; D S Karow; D P Salmon; C Fennema-Notestine
Journal:  Neurobiol Aging       Date:  2008-10-05       Impact factor: 4.673

8.  Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

Authors:  K B Walhovd; A M Fjell; J Brewer; L K McEvoy; C Fennema-Notestine; D J Hagler; R G Jennings; D Karow; A M Dale
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

9.  Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis.

Authors:  S Minoshima; K A Frey; N L Foster; D E Kuhl
Journal:  J Comput Assist Tomogr       Date:  1995 Jul-Aug       Impact factor: 1.826

10.  Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects.

Authors:  Laura M Parkes; Waqar Rashid; Declan T Chard; Paul S Tofts
Journal:  Magn Reson Med       Date:  2004-04       Impact factor: 4.668

View more
  13 in total

Review 1.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

2.  Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum.

Authors:  Gemma Salvadó; Marta Milà-Alomà; Mahnaz Shekari; Nicholas J Ashton; Grégory Operto; Carles Falcon; Raffaele Cacciaglia; Carolina Minguillon; Karine Fauria; Aida Niñerola-Baizán; Andrés Perissinotti; Andréa L Benedet; Gwendlyn Kollmorgen; Ivonne Suridjan; Norbert Wild; José Luis Molinuevo; Henrik Zetterberg; Kaj Blennow; Marc Suárez-Calvet; Juan Domingo Gispert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-18       Impact factor: 10.057

3.  Sparse canonical correlation analysis relates network-level atrophy to multivariate cognitive measures in a neurodegenerative population.

Authors:  Brian B Avants; David J Libon; Katya Rascovsky; Ashley Boller; Corey T McMillan; Lauren Massimo; H Branch Coslett; Anjan Chatterjee; Rachel G Gross; Murray Grossman
Journal:  Neuroimage       Date:  2013-10-02       Impact factor: 6.556

Review 4.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Li Shen; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-08-07       Impact factor: 21.566

5.  Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI.

Authors:  Val J Lowe; Patrick J Peller; Stephen D Weigand; Catalina Montoya Quintero; Nirubol Tosakulwong; Prashanthi Vemuri; Matthew L Senjem; Lennon Jordan; Clifford R Jack; David Knopman; Ronald C Petersen
Journal:  Neurology       Date:  2013-05-03       Impact factor: 9.910

6.  Longitudinal tau accumulation and atrophy in aging and alzheimer disease.

Authors:  Theresa M Harrison; Renaud La Joie; Anne Maass; Suzanne L Baker; Kaitlin Swinnerton; Laura Fenton; Taylor J Mellinger; Lauren Edwards; Julie Pham; Bruce L Miller; Gil D Rabinovici; William J Jagust
Journal:  Ann Neurol       Date:  2019-01-17       Impact factor: 10.422

7.  Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.

Authors:  Fabrizio De Carli; Flavio Nobili; Marco Pagani; Matteo Bauckneht; Federico Massa; Matteo Grazzini; Cathrine Jonsson; Enrico Peira; Silvia Morbelli; Dario Arnaldi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-31       Impact factor: 9.236

Review 8.  A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.

Authors:  Emma Lawrence; Carolin Vegvari; Alison Ower; Christoforos Hadjichrysanthou; Frank De Wolf; Roy M Anderson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.

Authors:  Sebastian Palmqvist; Michael Schöll; Olof Strandberg; Niklas Mattsson; Erik Stomrud; Henrik Zetterberg; Kaj Blennow; Susan Landau; William Jagust; Oskar Hansson
Journal:  Nat Commun       Date:  2017-10-31       Impact factor: 14.919

10.  Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment.

Authors:  Gretel Sanabria-Diaz; Eduardo Martínez-Montes; Lester Melie-Garcia
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.